

ImCheck Therapeutics, a French biotech company, has raised $53 million in Series B financing. Pfizer Ventures and Bpifrance led the round.
Source: Press Release
ImCheck Therapeutics, a French biotech company, has raised $53 million in Series B financing.
ImCheck Therapeutics, a French biotech company, has raised $53 million in Series B financing. Pfizer Ventures and Bpifrance led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination